Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
10/07/1998 | EP0868196A1 Synthetic vaccine for protection against human immunodeficiency virus infection |
10/07/1998 | EP0868183A1 Injectable quinolone formulations |
10/07/1998 | EP0868170A1 Composition base for topical therapeutic and cosmetic preparations |
10/07/1998 | EP0853627A4 Substituted liposaccharides useful in the treatment and prevention of endotoxemia |
10/07/1998 | EP0765165A4 Constrained peptides |
10/07/1998 | CN1195375A Angiostatin fragments and aggregate angiostatin and methods of use |
10/07/1998 | CN1195346A Preparation of triazoles by organometallic addition to ketones and intermediates therefor |
10/07/1998 | CN1195340A Inhibitors of farnesyl-protein transferase |
10/07/1998 | CN1195297A Clostridium difficile toxins as mucosal adjuvants |
10/07/1998 | CN1195288A Use of fluconazole for inhibiting growth of cancers |
10/07/1998 | CN1194984A Bismuth salts of antibiotics of moenomycin group, processes for their preparation, their use and pharmaceuticals comprising such salts |
10/07/1998 | CN1040116C Liponucleotide compounds, pharmaceutical composition and its use |
10/07/1998 | CN1040115C 5-methyluridine process for large-scale preparation of 2,3-didehydro-3-deoxythymidine (d4T) |
10/07/1998 | CN1040109C Novel cephalosporin antibiotics and processes for preparation thereof |
10/06/1998 | US5817820 Enantiomorphs, antibacterial agents |
10/06/1998 | US5817807 Containing a 1,4,8,11-tetraazacyclotetradecane ring |
10/06/1998 | US5817799 2'-Fluorofuranosyl derivatives and methods for preparing 2'-fluoropyrimidine and 2'-fluoropurine nucleosides |
10/06/1998 | US5817754 Tandem synthetic HIV-1 peptide |
10/06/1998 | US5817742 Polymer-conjugated malonic acid derivatives and their use as medicaments and diagnostic agents |
10/06/1998 | US5817687 Leukemia |
10/06/1998 | US5817686 Methods of combatting infectious diseases using dicationic bis-benzimidazoles |
10/06/1998 | US5817643 Immunostimulants |
10/06/1998 | US5817633 Using (mono or oligo)saccharides to bind to toxins; neutralization, removal from intestines |
10/06/1998 | US5817618 Protein isolated from mussels, glycogen |
10/06/1998 | US5817617 Selectin and pertussis toxin derived peptides and uses thereof |
10/06/1998 | US5817494 Anticancer agents; viricides |
10/06/1998 | US5817322 Pharmaceutical base and the use of the same |
10/06/1998 | US5817317 Clostridium perfringens vaccines |
10/06/1998 | US5817316 Immunogenic peptides, antibodies and uses thereof relating to CD4 receptor binding |
10/06/1998 | US5817314 Quillaja saponin adjuvant and vaccine formulation containing same |
10/06/1998 | US5817312 Sprayable immunoglobulins |
10/06/1998 | CA2136841C Novel piperidyl amides, sulfonamides and sulfoxamides as inhibitors of cholesterol biosynthesis |
10/06/1998 | CA1340071C Dectection of infectious and inflammatory lesions using anti-leukocyte conjugates |
10/04/1998 | CA2234139A1 Benzamide derivative, anti-ulcer drug, and antibacterial drug |
10/04/1998 | CA2234134A1 Pyrrolidine derivative, anti-ulcer drug, and antibacterial drug |
10/04/1998 | CA2233934A1 Alkylenediamine derivative, anti-ulcer drug, and antibacterial drug |
10/02/1998 | CA2233787A1 Sialoadhesin family member-3 |
10/02/1998 | CA2232884A1 Synergistic herbal extracts |
10/02/1998 | CA2223021A1 Novel human neurotensin receptor type 2 and splice variants thereof |
10/01/1998 | WO1998043182A1 Coincidence detection method, products and apparatus |
10/01/1998 | WO1998042868A2 Screening method for proline-rich proteins |
10/01/1998 | WO1998042847A2 Papilloma virus main capsid protein and the use thereof in diagnosis, therapy and vaccination |
10/01/1998 | WO1998042820A1 Use of the antibacterial active substance triclocarbane in liquid soaps |
10/01/1998 | WO1998042740A2 Compounds and methods for the diagnosis and treatment of ehrlichia infection |
10/01/1998 | WO1998042718A1 Method for generating saccharide fragments |
10/01/1998 | WO1998042705A1 Salt of naphthyridine carboxylic acid derivative |
10/01/1998 | WO1998042375A1 Detoxified mutants of bacterial adp-ribosylating toxins as parenteral adjuvants |
10/01/1998 | WO1998042372A1 CARBOHYDRATE ANTIGENS WHICH IMMUNOREACT WITH POLYCLONAL ANTISERA AGAINST $i(H. PYLORI) |
10/01/1998 | WO1998042365A1 Ligand/lytic peptide compositions and methods of use |
10/01/1998 | WO1998042364A1 Ligand/lytic peptide compositions and methods of use |
10/01/1998 | WO1998042354A1 Chemokines that inhibit immunodeficiency virus infection and methods based thereon |
10/01/1998 | WO1998042351A1 Difluoronucleoside phosphonic acids and derivatives thereof |
10/01/1998 | WO1998042349A1 Mixtures of at least two reverse transcriptase inhibitors and hydroxycarbamide, in particular for inhibiting retroviral spread |
10/01/1998 | WO1998042321A2 Liquid compositions comprising lamivudine |
10/01/1998 | WO1998042318A1 Pellets having a core coated with an antifungal and a polymer |
10/01/1998 | WO1998042313A1 Opthalmic non-irritating iodine medicament and method |
10/01/1998 | WO1998042188A1 Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases |
10/01/1998 | WO1998025593A3 2-cyclopenten-1-one and its derivatives as inhibitors of the nf-kb factor |
10/01/1998 | DE19712410A1 Verwendbarkeit des antibakteriellen Wirkstoffes Triclocarban in Flüssigseifen Usability of the antibacterial agent triclocarban in liquid soaps |
10/01/1998 | CA2285480A1 Screening method for proline-rich proteins |
10/01/1998 | CA2285394A1 Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases |
10/01/1998 | CA2284776A1 Use of the antibacterial active substance triclocarbane in liquid soaps |
10/01/1998 | CA2284696A1 Opthalmic non-irritating iodine medicament and method |
10/01/1998 | CA2284671A1 Carbohydrate antigens which immunoreact with polyclonal antisera against h. pylori |
10/01/1998 | CA2284633A1 Chemokines that inhibit immunodeficiency virus infection and methods based thereon |
10/01/1998 | CA2284606A1 Method for generating saccharide fragments |
10/01/1998 | CA2284483A1 Mixtures of at least two reverse transcriptase inhibitors and hydroxycarbamide, in particular for inhibiting retroviral spread |
10/01/1998 | CA2284263A1 Difluoronucleoside phosphonic acids and derivatives thereof |
10/01/1998 | CA2284251A1 Compounds and methods for the diagnosis and treatment of ehrlichia infection |
09/30/1998 | EP0867515A1 Process for the isolation of a pharmaceutically acceptable alkali metal salt of clavulanic acid |
09/30/1998 | EP0867513A2 Interleukin-1 beta converting enzyme apoptosis protease-10 |
09/30/1998 | EP0867509A2 Tumor necrosis related receptor, TR5 |
09/30/1998 | EP0867508A2 Olfactory receptor of the 7-transmembrane receptor family - OLRCC15 receptor |
09/30/1998 | EP0867507A1 LicB polypeptides from Streptococcus pneumoniae |
09/30/1998 | EP0867438A1 Rapamycin derivatives and their use, particularly as immunosuppressants |
09/30/1998 | EP0866865A1 Chimeric oligomers having an rna-cleavage activity |
09/30/1998 | EP0866864A2 Antifungal proteins |
09/30/1998 | EP0866863A1 Antifungal proteins |
09/30/1998 | EP0866857A1 E6 binding proteins |
09/30/1998 | EP0866852A1 Tissue-specific and target rna-specific ribozymes |
09/30/1998 | EP0866803A1 Transferrin receptor protein of moraxella |
09/30/1998 | EP0866801A1 Cyclopeptolides |
09/30/1998 | EP0866793A1 Nitroimidazole antibacterial compounds and methods of use thereof |
09/30/1998 | EP0866791A1 Diaminopyrimidines, pharmaceutical compositions containing them and their use as antibacterial |
09/30/1998 | EP0866718A1 Use of toxin peptides and/or affinity handles for the delivering compounds into cells |
09/30/1998 | EP0866716A1 Methods of treating disorders of non-visual sensory epithelia |
09/30/1998 | EP0866700A1 Hemoregulatory compounds |
09/30/1998 | EP0866698A1 Hemoregulatory compounds |
09/30/1998 | EP0866696A1 Treatment of the cns effects of hiv with vx-478, alone or in combination with azt or 3tc |
09/30/1998 | EP0866656A1 Inhibition of tumor necrosis factor alpha |
09/30/1998 | EP0866654A1 Method for treating hepatitis virus infection |
09/30/1998 | EP0577646B1 Sustained release drug delivery devices |
09/30/1998 | EP0551460B1 HCV peptide-antigens and a method of testing for the hepatitis C virus (HCV) |
09/30/1998 | CN1194582A Anti fungal agent, compound therefor, process for producing the same |
09/30/1998 | CN1040002C Process for preparing diastereoisomer of 3-cephem-4-carbon acid-1-(isopropxycabonyloxy) ethylester |
09/30/1998 | CN1040001C Process for preparing cephalosporin compounds from reactive organic acid derivatives |
09/29/1998 | US5814639 Treating aids |
09/29/1998 | US5814634 Alkylenediamine derivative anti-ulcer drug and antibacterial drug |
09/29/1998 | US5814510 Attenuated canine parvovirus vaccine |
09/29/1998 | US5814475 Antibodies and dna for drugs and diagnosis |